VSV oncoselectivity does not rely on selective attachment to cancer cells; rather, it stems from the frequent deficiencies in type I interferon (IFN) signaling found in many tumors, a critical factor that allows VSV to preferentially replicate in cancer cells. This evidence concerns the gene IFNA1 and cancer.